FADS2 and cancer: Meanwhile, the FADS2 expression level was mainly upregulated in malignant tumor cells, epithelial cells, mast cells, and macrophages, whereas it was extremely low in CD4 Tconv cells, Treg cells, plasma cells, and neutrophils (Fig. 6B).